Search Orphan Drug Designations and Approvals
-
Generic Name: | amifampridine phosphate |
---|---|
Date Designated: | 08/31/2016 |
Orphan Designation: | Treatment of myasthenia gravis |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 03/14/2024 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Catalyst Pharmaceuticals, Inc. 355 Alhambra Circle Suite 1250 Coral Gables, Florida 33134 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-